Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{151109, author = {Shubham S. Vairagkar and Shyamlila B. Bavage and Nandkishor B. Bavage and Prof.Dr.G.Vidyasagar and Ganesh S. Lad}, title = {Cancer review article}, journal = {International Journal of Innovative Research in Technology}, year = {}, volume = {7}, number = {11}, pages = {619-626}, issn = {2349-6002}, url = {https://ijirt.org/article?manuscript=151109}, abstract = {At present, in the modern oncology the damage of the genetic material of the cell is considered to be the primary cause of cancer, and the pathogenesis of cancer is seen as a process of transformation of a normal cell into a tumor cell, as evidenced by deep fundamental research of the pathogenesis of cancer, which is held exclusively at the cellular, molecular and genetic levels. A new growth of tissue called as cancer and the generated new growth called as tumour or any abnormal growths of new tissue called as neoplasm. This is result of excessive, uncontrolled, autonomous, proliferation of tissues as compere to normal tissues of the body. Neoplasia is a Latin word means the new growth of tissues. Neoplasm can be recognised by formation of masses of tissues which may be benign or malignant tumor. And the study of tumor called as oncology. Surprisingly, this unfavourable prognosis has been made while the annual financing of scientific research of the cancer problem in the world is increasing enormously, as well as the scholars’ optimism regarding the rapid creation of effective cancer drugs. Despite the availability of the important basic knowledge about the cancer biology, the obstacle to the creation of effective cancer treatment in humans exists. In our opinion, this obstacle is the lack of the true pathogenesis of malignant tumor. }, keywords = {Neoplasia, genetic material, malignant tumor, normal tissues.}, month = {}, }
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry